Should You Limit or Avoid Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) With Crohn’s Disease?

However, you may be able to get by with some NSAID use if your doctor gives you the go-ahead. “Newer data shows that short courses of NSAIDs are well tolerated without causing any exacerbation of Crohn’s disease or ulcerative colitis,” says Jill Gaidos, MD, a gastroenterologist with Yale Medicine in New Haven, Connecticut, and associate professor of medicine at the Yale School of Medicine.
Why You May Need to Limit or Avoid NSAIDs With Crohn’s
NSAIDs can damage the lining of your gastrointestinal tract (intestinal mucosa), says Dr. Alexis. “Damage to the intestinal mucosa can trigger a cascade of inflammation that may lead to a severe disease flare, potentially requiring hospitalization.”
“In general, prolonged use of NSAIDs can cause ulcers in the upper GI tract, which can result in bleeding as well as anemia,” says Gaidos. “For that reason, we don’t recommend long-term NSAID use, or we recommend adding an acid-suppression medication to try to prevent injury to the upper GI tract for anyone who needs long-term NSAIDs.”
Short-term use is typically well-tolerated, says Gaidos, who recommends NSAIDs for her patients with Crohn’s who have a musculoskeletal injury (such as a muscle sprain or bone fracture) or need additional pain relief for no more than two weeks.
5 Alternatives to NSAIDs for Crohn’s Pain
Be sure to talk to your doctor about any pain you’re experiencing. They can help you identify the source of the pain and recommend a medication or another strategy that’s safest and most helpful for you. Some options that may help you get relief include:
1. Acetaminophen (Tylenol)
2. Gut Nerve Medications
- Serotonin-norepinephrine reuptake inhibitors (SNRIs) like venlafaxine (Effexor), desvenlafaxine (Pristiq), duloxetine (Cymbalta), levomilnacipran (Fetzima), and milnacipran (Savella)
- Selective serotonin reuptake inhibitors (SSRIs) like citalopram (Celexa), escitalopram (Lexapro), fluoxetine (Prozac), fluvoxamine (Luvox), paroxetine (Paxil), and sertraline (Zoloft)
- Tricyclic antidepressants like amitriptyline, nortriptyline (Pamelor, Aventyl), doxepin (Sinequan, Adapin)
- Bupropion (Wellbutrin, Zyban)
3. Corticosteroids
4. Tramadol (Ultram)
- codeine
- hydrocodone
- oxycodone
- morphine
- hydromorphone
- fentanyl
5. Complementary Therapies
Instead of (or alongside) pain medications, you can try complementary therapies to reduce your Crohn’s pain.
“Different activities help with different types of pain,” says Gaidos, who recommends exercise, stretching, physical therapy, and massage for joint or musculoskeletal pain. For abdominal pain that isn’t connected to active Crohn’s disease, Gaidos suggests mind-body approaches like yoga, cognitive behavior therapy (a form of talk therapy with a mental health professional), or gut hypnosis (a form of therapy given by a trained professional to improve communication between the gut and brain).
- Yoga
- Acupuncture
- Dietary changes
- Physical activity
- Mindfulness-based stress reduction
- Virtual reality distraction
- Behavioral therapies
- Relaxation training
- Massage
The Takeaway
- Nonsteroidal anti-inflammatory drugs (NSAIDs) can make Crohn’s symptoms worse, although studies have not shown this consistently.
- Worsened Crohn’s symptoms are more likely when taken longer than two weeks, so it’s best to avoid these medications as much as possible unless your doctor says otherwise.
- Instead of NSAIDs, your healthcare provider may recommend acetaminophen (Tylenol), antidepressants, steroids, complementary therapies, or, rarely, opioids to manage your pain.
- If you experience pain with Crohn’s and don’t know what to take for relief, talk to your provider, who can suggest medications or other options to ease your discomfort.
Resources We Trust
- Mayo Clinic: Living With Crohn’s Disease or Colitis
- Cleveland Clinic: Crohn’s Disease
- Crohn’s & Colitis Foundation: Pain Management for IBD Patients
- American Medical Association: What Doctors Wish Patients Knew About Inflammatory Bowel Disease
- Crohn’s and Colitis Canada: Pain Management
- Hunter T et al. Medication Use Among Patients With Crohn’s Disease or Ulcerative Colitis Before and After the Initiation of Advanced Therapy. BMC Gastroenterology. November 19, 2022.
- Lichtenstein GR et al. ACG Clinical Guideline: Management of Crohn’s Disease in Adults. The American Journal of Gastroenterology. June 2025.
- Sohail R et al. Effects of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and Gastroprotective NSAIDs on the Gastrointestinal Tract: A Narrative Review. Cureus. April 3, 2023.
- Cohen-Mekelburg S et al. The Association Between Nonsteroidal Anti-Inflammatory Drug Use and Inflammatory Bowel Disease Exacerbations: A True Association or Residual Bias? The American Journal of Gastroenterology. November 2022.
- Okafor PN. NSAID Use and the Risk of IBD Exacerbations: Fact or Fiction? American College of Gastroenterology. December 14, 2022.
- Coates MD et al. Abdominal Pain in Inflammatory Bowel Disease: An Evidence-Based, Multidisciplinary Review. Crohn’s & Colitis 360. September 26, 2023.
- Weston F et al. Antidepressant Treatment in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis. European Journal of Gastroenterology & Hepatology. July 2024.
- The Gut-Brain Connection. Cleveland Clinic. September 20, 2023.
- Keefer L et al. AGA Clinical Practice Update on Pain Management in Inflammatory Bowel Disease: Commentary. Gastroenterology. June 2024.
- Hatamnejad MR et al. Selective Serotonin Reuptake Inhibitors and Inflammatory Bowel Disease; Beneficial or Malpractice. Frontiers in Immunology. October 5, 2022.
- Bruscoli S et al. Glucocorticoid Therapy in Inflammatory Bowel Disease: Mechanisms and Clinical Practice. Frontiers in Immunology. June 3, 2021.
- da Silva BC. Corticosteroid-Free Remission in Patients With Inflammatory Bowel Disease. Gastroenterology & Hepatology. March 2024.
- Prescription Opioids DrugFacts. National Institute on Drug Abuse. June 2021.
- Pain Management for IBD Patients. Crohn’s & Colitis Foundation.

Yuying Luo, MD
Medical Reviewer
Yuying Luo, MD, is an assistant professor of medicine at Mount Sinai West and Morningside in New York City. She aims to deliver evidence-based, patient-centered, and holistic care for her patients.
Her clinical and research focus includes patients with disorders of gut-brain interaction such as irritable bowel syndrome and functional dyspepsia; patients with lower gastrointestinal motility (constipation) disorders and defecatory and anorectal disorders (such as dyssynergic defecation); and women’s gastrointestinal health.
She graduated from Harvard with a bachelor's degree in molecular and cellular biology and received her MD from the NYU Grossman School of Medicine. She completed her residency in internal medicine at the Icahn School of Medicine at Mount Sinai, where she was also chief resident. She completed her gastroenterology fellowship at Mount Sinai Hospital and was also chief fellow.

Abby McCoy, RN
Author
Abby McCoy is an experienced registered nurse who has worked with adults and pediatric patients encompassing trauma, orthopedics, home care, transplant, and case management. She is a married mother of four and loves the circus — that is her home! She has family all over the world, and loves to travel as much as possible.
McCoy has written for publications like Remedy Health Media, Sleepopolis, and Expectful. She is passionate about health education and loves using her experience and knowledge in her writing.